Professor Dr. Mohammad Kamil, M.Sc.; M.Phil.; Ph.D.; D.Sc.; Chartered Chemist(U.K.) and Fellow Royal Society of Chemistry (London), worked in various capacities, as In-charge –of the Drug Standardization lab. Professor & Head Department of Pharmacognostic Science, Zayed Complex for Herbal Research & Traditional. Medicine(ZCHRTM), Ministry of Health, UAE (1996-2010); Head TCAM Research at ZCHRTM, Department of Health(DOH)Abu Dhabi (2010-2020), presently working as Director General, Lotus Holistic Healthcare Institute, Abu Dhabi, UAE since 2021 and Head, Scientific Committee for Sheikh Zayed International TCAM Awards and General Secretary for First Sheikh Zayed TCAM International Award October 2024. He is a recipient of Man of the year 2002, ABI, USA; Hakim Ajmal Khan Global Award in Unani Medicine, India(2014); Honorary Trustee, International Unani Forum (Oct’2022 -March 2025). More than 700 research papers in reputed journals & and presentations at international conferences are at his credit. He has been associated with the World Health Organization (WHO) in the revision of the Benchmark for International Standards of Unani Medicine Terminology and Training of Unani Medicine, as its drafting expert and their subsequent reviews.

Julissa Soto, an independent health equity consultant, is an expert in health care access and focuses her efforts in support of the Latino community. She serves as Vaccine Sunday Ambassador for Immunize Colorado, a statewide non-profit that works to protect Colorado families, schools and communities from vaccine-preventable diseases. Immunize Colorado is dedicated to keeping Colorado communities healthy by building awareness for vaccines, educating health care providers, and advocating for policies that protect children with the goal of increasing childhood vaccination rates. As Colorado’s only statewide independent nonprofit organization committed to keeping Coloradans healthy through immunization, the organization elevates the essential role vaccines play in preventing illness and promoting health for all of Colorado.

Dr. Shankar is an Assistant Professor (Research) in the Division of Medical Oncology, Department of Internal Medicine, at The Ohio State University, Columbus, Ohio, USA. Trained as a neuroscientist, Dr. Shankar holds a Ph.D. in Molecular Neurobiology from Cochin University of Science and Technology, Kerala India. Driven by a deep commitment to advancing cancer research, Dr. Shankar has dedicated their career to deciphering the molecular complexities of breast and prostate cancers. His research is anchored in uncovering novel chemotherapeutic and chemopreventive approaches, particularly by leveraging the potential of drug repurposing. At the heart of Dr. Shankar's research is an innovative focus on Enhancer of Zeste Homolog 2 (EZH2), a critical epigenetic regulator involved in cancer progression. Recognizing its role in the aggressive and metastatic behaviors of breast and prostate cancers, Dr. Shankar and their team are pioneering the development of combinatorial treatments targeting EZH2. This groundbreaking research, supported by funding from the Department of Defense, USA, aims to provide new therapeutic strategies to combat Triple Negative Breast Cancer in the United States. By integrating drug repurposing strategies with advanced molecular insights, Dr. Shankar's work contributes to a promising frontier in oncology, with the potential to yield highly targeted, effective treatments for patients facing advanced breast and prostate cancers.

Dr. David Wortley is Vice President of the International Society of Digital Medicine (ISDM). Virtual Conferences Director at IORMA Global Commerce Consultancy. CEO and Founder of 360in360 Immersive Experiences. Expert Consultant on Gamification and Enabling Technologies. Authority on the practical application of immersive technologies and gamification in health, business and education.

Prof. Adetoro Adegoke joins Buckinghamshire New University as Professor of Health Inequalities and the Director, Centre for Excellence in Health Inequalities. Her work focuses on reducing health inequalities, improving health, strengthening health care systems and strengthening the capacity of health training institutions. She has over 26 years’ experience in health care delivery; higher education teaching and learning; and training, including over 16 years consulting and/or full-time experience in international development and leading multi-country research including in fragile or post-conflict states with special focus on health and wellbeing, equitable health, quality education, gender equality and women and girls’ empowerment. She has extensive experience initiating, developing, implementing and evaluating research in many countries including leading multi-country research as Principal Investigator across Africa and Asia (Nigeria, Malawi, Sierra Leone, Kenya, South Africa and Tanzania; Bangladesh, Nepal, India and Pakistan). Adetoro is an editorial board member for the Austin Journal of Tropical Medicine and Hygiene and the International Journal of Nursing Education and Practice and a reviewer for many journals. Professor Adegoke has extensive experience providing Reproductive Maternal Newborn and Child Adolescent Health (RMNCAH) technical assistance and leading health programmes in 17 Low- and Middle-Income countries in Africa, Asia and South America (Bangladesh, Bolivia, Democratic Republic of Congo (DRC), Ghana, India, Indonesia, Kenya, Liberia, Malawi, Nigeria, Pakistan, Sierra-Leone, Somalia, South Sudan, Tanzania, Zambia, Zimbabwe). Adetoro over many years has developed, significantly contributed to, and is an internationally well-recognised expert in the field of global public health. She is a thought leader in reproductive health; maternal health; maternal mortality; skilled birth attendance; humanitarian-development nexus; decolonisation in global health; human resources for health; midwifery; and reproductive, maternal and newborn health needs in fragile and conflict situations. As a thought leader in global health, she has been a force developing and implementing policies to reduce health inequalities; framing access to health and education and has led dialogues about equity, equality, inclusion, social justice and social impact.

Experienced General Manager with a demonstrated history of working in the healthcare informatics, wellness, behavioral health, and financial industries. Skilled in domestic and international Start-Ups, Negotiation, Business Planning, International Acquisitions, Adapting and Launching Products in Foreign Cultures, Team Building, and Finance. Strong business development professional with a MS from the Massachusetts Institute of Technology focused in Finance and Operations Research. Series 7 credential. Fluent in three languages and has 20 years’ international experience.

Dr. Anand Srivastava is a Chairman and Cofounder of California based Global Institute of Stem Cell Therapy and Research (GIOSTAR) headquartered in San Diego, California, (U.S.A.). The company was formed with the vision to provide stem cell based therapy to aid those suffering fromdegenerative or genetic diseases around the world such as Parkinson's, Alzheimer's, Autism, Diabetes, Heart Disease, Stroke, Spinal Cord Injuries, Paralysis, Blood Related Diseases, Cancer and Burns. Dr. Srivastava has been associated with leading universities and research institutions of USA. In affiliation with University of California San Diego Medical College (UCSD), University of California Irvine Medical College (UCI), Salk Research Institute, San Diego, Burnham Institute For Medical Research, San Diego, University of California Los Angeles Medical College (UCLA), USA has developed several research collaborations and has an extensive research experience in the field of Embryonic Stem cell which is documented by several publications in revered scientific journals. Furthermore, Dr. Srivastava’s expertise and scientific achievements were recognized by many scientific fellowships and by two consecutive award of highly prestigious and internationally recognized, JISTEC award from Science and Technology Agency, Government of Japan. Also, his research presentation was awarded with the excellent presentation award in the “Meeting of Clinical Chemistry and Medicine, Kyoto, Japan. Based on his extraordinary scientific achievements his biography has been included in “WHO IS WHO IN AMERICA” data bank two times, first in 2005 and second in 2010.